PACS Group Inc header image

PACS Group Inc

PACS

Equity

ISIN US69380Q1076 / Valor 133777092

New York Stock Exchange, Inc (2024-09-16)
USD 40.97+0.61%

PACS Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

PACS Group, Inc. (PACS) is a holding company that has significantly expanded its footprint in the healthcare sector, specifically focusing on the post-acute care industry since its inception in 2013. Starting with just two skilled nursing facilities, PACS has grown into a substantial network, now encompassing over 200 facilities across nine states. The company's growth strategy involves investing in post-acute care facilities, healthcare professionals, and ancillary services to provide comprehensive care. PACS emphasizes a model that combines the benefits of a national support network with the autonomy of local decision-making in its operations. As of now, PACS and its affiliates manage 218 facilities, employing over 32,000 staff members, and cater to the daily needs of more than 20,000 patients and residents. This expansion reflects PACS's commitment to delivering mission-driven care and addressing the growing demand for post-acute healthcare services in the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (12.06.2024):

Revenue Growth

PACS Group Inc. reported a significant increase in revenue for the first quarter of 2024, with consolidated GAAP revenue reaching $934.7 million. This represents a 31.9% increase over the same quarter in the previous year, driven by both an increase in occupancy rates and the addition of new facilities.

Net Income and Earnings Per Share

For the first quarter of 2024, PACS Group Inc. achieved a net income of $49.1 million, which is a 30.7% increase compared to the first quarter of the previous year. The GAAP earnings per share also rose by 31.0% to $0.38, reflecting the company's strong financial performance and operational efficiency.

Adjusted EBITDA and EBITDAR

The company's EBITDA for the first quarter of 2024 stood at $96.3 million, showing a 47.0% increase from the previous year. Adjusted EBITDA was reported at $88.5 million, up by 34.0%, and Adjusted EBITDAR reached $152.5 million, highlighting effective cost management and operational improvements.

Operational Highlights

During the first quarter of 2024, PACS Group Inc. maintained a strong operational performance with an occupancy rate of 91.1%. The company also expanded its portfolio by adding 10 new operating facilities, which included 1,334 skilled nursing and 174 assisted living beds, enhancing its service capacity and market reach.

Future Outlook

Looking ahead to the full year of 2024, PACS Group Inc. has provided a revenue guidance of between $3.65 billion to $3.75 billion and an Adjusted EBITDA forecast of $351 million to $361 million. This outlook is based on the company's current operations and market conditions as of May 13, 2024, reflecting confidence in continued growth and operational success.

Summarized from source with an LLMView Source

Key figures

%1Y
%3Y
%5Y

Performance

46.4%1Y
46.4%3Y
46.4%5Y

Volatility

Market cap

6358 M

Market cap (USD)

Daily traded volume (Shares)

144,434

Daily traded volume (Shares)

1 day high/low

41.5 / 40.65

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Illumina Inc
Illumina Inc Illumina Inc Valor: 1111080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%USD 129.52
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.01%CHF 78.20
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.92%USD 270.37
Waystar Holding Corp
Waystar Holding Corp Waystar Holding Corp Valor: 130358792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%USD 27.28
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.39%USD 249.56
Intuitive Surgical Inc
Intuitive Surgical Inc Intuitive Surgical Inc Valor: 1631646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.31%USD 491.39
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 196.45
Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%USD 69.87
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.04%USD 113.97
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%EUR 52.40